On January 20, the "Shanghai Biomedical Industry Development White Paper" was released
.
The white paper pointed out that by 2025, the scale of Shanghai's biopharmaceutical industry will exceed 1,000 billion yuan, of which the manufacturing output value will reach 240 billion yuan; a total of 26,000 mu of available space will be launched, and 6 industrial parks of 10 billion will be built; "14th Five-Year Plan" During the period, the cumulative number of domestic Class 1 innovative drugs and innovative medical device products reached 15 and 35 respectively; 25 new listed companies were added
.
